Global Infusion Therapy Market 2025 – 2034

Reports Description

Global Infusion Therapy Market size was valued at USD 38,926.03 Million in 2025 and is expected to reach USD 96,390.96 Million by 2034 at a CAGR of 10.6% during the forecast period 2025 – 2034.

Infusion therapy is used to treat medical conditions, such as infections and diseases, which do not respond to oral antibiotics. An infusion therapy provider specializes in administering infusion treatments to patients in their homes or other alternative settings. It is known as Home Infusion Therapy Pharmacy.

Extensive service, prescription drugs, and biologics can be administered safely and effectively in patients’ homes or other places. Increase in hospital-acquired infections (HA), due to contact with contaminated equipment, bedclothes, and airdrops, promoting market growth.

In addition, the demand for home infusion therapy is increasing to reduce the possibility of infection and to ensure the best possible care. The development of a low-cost, user-friendly home infusion kit is another factor driving the industry’s growth.

Infusion Therapy Market Growth Factors

Growing Shift Towards Home Medical Care

Since the healthcare sector has been seeing huge changes in the previous years, residential medical care is becoming a popular option for patients. Outpatient settings, including home care settings, have progressive fluctuations of patients and healthcare providers to treat non-mutable conditions.

Various benefits and profits, and private companies have entered the service sector and are training medical personnel for the distribution of infusion medical benefits to patients at home. The patient’s preference towards home infusion settings is estimated to increase shortly due to high patient facility and the launch of new, innovative remedies that can easily and safely be administered in a home setting.

In addition, the progress in technology, such as the use of wearables, advances in point-of-care technology, and increasing telemedicine has led to better remote monitoring and can lead to safe care in the house.

Various comparative studies have demonstrated adequate cost reduction to provide special infusion medicines in homes compared to hospital settings. For example, according to various studies, the cost of the IVIG infusion in the Accredo in the home infusion setting is 62% lower than the cost of the medical office administration and 87% lower than the cost of the hospital’s outpatient administration.

It is important in attracting a big patient pool towards adopting treatment at residence as a preferred treatment option. In addition, efforts were made by several healthcare organizations to promote home care, and there is a possibility of increasing demand for home infusion products and services during the forecast period.

Growing Geriatric Population and Increased Prevalence of Chronic Disease

The burden of chronic diseases is increasing globally. There has been a tremendous increase in the events of cancer, diabetes, chronic disease, congestive heart failure, and others. According to the World Health Organization (WHO), chronic diseases affect around 133 million Americans, which represents 40% of the country’s total population.

It predicts a large patient pool to suffer from chronic diseases, as well as patients passing through infusion therapy in the settings of the house.

The increase in the huge medical population is also increasing the growth of the market. This population is more prone to chronic diseases, which in turn results in high demand for treatment at home. For example, according to a survey conducted by the American Association of Retired People, most older adults prefer to live as long as possible in their homes.

In addition, according to Dartmouth Atlas researchers, in the U.S., more than 80% of patients want to be hospitalized and avoid intense care during the terminal phase of their lives and prefer to be treated at home. In cases of chronic diseases, not only the slight growth of the growing geriatric population but also the high proliferation of these diseases between children and small adults keeps increasing the chances of the future being operated on in the future.

In addition, increasing awareness about welfare related to home remedies in devices designed for home use and increasing awareness about welfare is probable to promote the demand for infusion of homes globally during the forecast period. There are additional factors.

Infusion Therapy Market Restraint

Limited Reimbursement for Home Care

The potential major factor to obstructs market development is the absence of reimbursement policies in many developing countries. Depending on the medical indication provided, the reimbursement rate is variable to the infusion of home.

Out-of-pocket expenditure on healthcare in emerging countries like India and China is higher than in other countries with an established reimbursement structure. The situation is more complex than a lack of reimbursement policies for home care settings in these countries.

It has disrupted the number of patients passing through home infusion therapy in emerging countries. This is expected to adopt these services, along with a limited number of public and private home infusion providers, trained medical personnel, and other limited resources in emerging countries.

Infusion Therapy Market Opportunities

The Increase in The Number of Cancer-Propelling Infusion Therapy

Cancer is the second major cause of death worldwide. This is caused due to the development of abnormal cells, which further divide uncontrollably. These abnormal cells form a mass-like structure called tumours. The most common cancers are breast, prostate, lung, colon, and rectum.

Diabetes is another chronic disease that causes many deaths.  According to the Disease Control and Prevention Centres, diabetes killed more than 37 million people in the U.S.  Also, Heart disease is the leading cause of death globally.

Heart attack and stroke are the most common acute phenomena. These are mainly caused by obstruction of blood vessels, which prevents blood from flowing into the brain or heart. The causes of heart failure may include unhealthy diets and addictions such as tobacco and smoking. Thus, due to the growing incidence of these chronic diseases, the number of infusion treatments increases, which drives the demand of the infusion therapy market.

Infusion Therapy Market Challenge

Risk of Infections Associated with Infusion Therapy:

The risk of infusion therapy infections is a major concern for patients for domestic infusion treatment. Infusion-related bloodstream infections lead to serious health complications and sometimes may also have mortality. While hospitals have strong protocols and sterile environments to reduce such risks, maintaining equal hygiene and safety standards at home is challenging.

Many patients and their families are afraid that common home settings cannot perfectly limit the risk of contamination in IV lines, catheters, or infusion pumps. This hesitates them to accept long-term infusion associated with continuous trips by nursing staff at home. Many patients require prolonged infusion treatments for chronic conditions such as cancer and multiple sclerosis; this factor hampers the market growth.

Infusion Therapy Market Segmentation Analysis

Global Infusion Therapy market is segmented by product, by application, end user and by region. Based on the product, the infusion therapy market is segmented into Infusion pumps, Intravenous Sets, IV Cannulas, and Needleless Connectors.

Among all of these, the infusion pump segment dominated the market in 2024 and is expected to keep its dominance during the forecast period, which is due to its versatility and suitability to give a variety of treatments. An infusion pump allows accuracy in drug delivery directly through an IV, offering patients more autonomy and control of their treatment.

The need for infusion pumps is driven by its extensive use in chemotherapy and diabetes treatment. Also, for chemotherapy patients, infusion pumps allow home-based administration of drugs for an extended period, increasing the quality of life by reducing hospital visits. They also help in controlling the drug doses more accurately than manual methods.

Also, insulin-dependent diabetic patients rely on infusion pumps to maintain stable glucose levels outside the hospital setting. Advanced pump facilities such as adaptable basal rate programs and integrated glucose monitors also provide distance monitoring by healthcare providers.

Based on the application, the infusion therapy market is segmented into Anti-infective, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals, and others. Among all of these, the anti-infective therapy segment dominated the market in 2024 and is expected to keep its dominance during the forecast period.

One of the most prescribed infusion remedies is anti-infective therapy. However, there are some threats associated with this type of medicine that can be reduced by a multidisciplinary strategy including strict patient selection criteria, an organized follow-up procedure, and a focus on patient education.

Catheter sepsis, cellulitis, pneumonia, chronic urinary tract infection (UTI), cystic fibrosis (CF), and fungal infections are diseases that can be treated with infusion anti-infective drugs. As a result, the market tested is likely to be inspired by an increase in the incidence of various infectious diseases in the market, established, and emerging markets.

Report Scope

Infusion Therapy Market Regional Analysis

By Region, Infusion therapy market is segmented into North America, Asia Pacific, Europe, Middle East & Africa and Latin America. Among all of these, the North America region dominated the market in 2024 and is expected to keep its dominance during the forecast period due to the increasing requirement of infusion remedies in the region.

In addition, factors such as the growing senior population in North America and high rates of cancer, AIDS, and diabetes are demanding infusion medical devices. According to the American Cancer Society, about 1,852,450 new cancer cases were diagnosed in the United States in 2023, and 568,880 cancer deaths occurred.

Breast cancer, lung cancer, prostate cancer, colorectal cancer, bladder cancer, and skin cancer are the most malignant in the United States. Additionally, due to low cost and increased patient dynamics, there is a growing migration from acute care to home care settings, which is likely to encourage further development.

The healthcare industry is increasing the demand for advanced, as well as the deployment of more advanced medical goods and regional products. Increased acceptance of non-hospital remedies and the huge base of iconic customers who require regular infusion treatment are demanding infusion therapy equipment in Europe.

In addition, the Asia Pacific market is expected to grow rapidly during the forecast period, which is due to the increasing incidence of diabetes, heart disease, cancer, and other chronic diseases in the region.

Infusion Therapy Market Recent Developments

• In January 2024, Brightstar Care gave the U.S. in collaboration with Paragon Healthcare to offer high-quality home infusion services.

• In August 2023, Neuronate Pro and Venfuse collaborated to offer advanced workflow solutions for infusion therapy in neurology practices.

• In June 2023, Yale New Haven Health and Carpathia announced a partnership for Home Infusion Services.

• In February 2022, Braun, the leading company in Braun, Medical Technology, and a provider of Infusion Therapy and Pen Management Solutions, received FDA approval for the Daytona Beach Pharmaceutical Manufacturing site.

List of the prominent players in the Infusion Therapy Market:

• Braun Melsungen AG
• Abbott Laboratories
• Fresenius Kabi AG
• Baxter
• Care Fusion Corporation
• Hospira Inc.
• AccuVein
• Stryker Corporation
• Vuetek Scientific
• Smiths Medical
• IV-EYE
• Veinlite
• Aetna
• Continuum Rx
• Evena
• Carecentrix
• Bristol-Myers Squibb
• Axela Care
• Tricare
• Eli Lilly and Company
• Others

The Infusion Therapy Market is segmented as follows:

By Product

• Infusion Pump
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

By Application

• Anti-infective
• Hydration Therapy
• Chemotherapy
• Enteral Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Other

By End-user

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Homecare Settings

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America